HER-2/neu and hTERT Cryptic Epitopes as Novel Targets for Broad Spectrum Tumor Immunotherapy-Reference-Cited by-同舟云学术

HER-2/neu and hTERT Cryptic Epitopes as Novel Targets for Broad Spectrum Tumor Immunotherapy

Published:2002-06-01 Issue:11 Volume:168 Page:5900-5906
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Scardino Antonio,Gross David-Alexandre,Alves Pedro,Schultze Joachim L.,Graff-Dubois Stéphanie,Faure Olivier,Tourdot Sophie,Chouaib Salem,Nadler Lee M.,Lemonnier François A.,Vonderheide Robert H.,Cardoso Angelo A.,Kosmatopoulos Kostas

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

2. Human tumor antigens recognized by T cells

3. HER-2/neu Protein: A Target for Antigen-Specific Immunotherapy of Human Cancer

4. hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization

5. Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TULIP: A transformer-based unsupervised language model for interacting peptides and T cell receptors that generalizes to unseen epitopes;Proceedings of the National Academy of Sciences;2024-06-05

2. Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase;Cancer Gene Therapy;2024-04-09

3. Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics;International Journal of Nanomedicine;2024-04

4. Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations;Frontiers in Cell and Developmental Biology;2023-11-15

5. Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors;Journal for ImmunoTherapy of Cancer;2021-07